Chodakewitz Jeffrey
Insider CIK 1610876 · TTPH Director · SDGR Director · PRAX Director · TORC Director · VRTX SVP GMDA, CMO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SDGR Schrodinger, Inc. | A Award deriv | 2026-06-22 | 2026-06-23 | 13,313 | — | $0 | 13,313 | SEC↗ |
| SDGR Schrodinger, Inc. | A Award | 2026-06-22 | 2026-06-23 | 8,141 | — | $0 | 25,388 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award deriv | 2026-06-21 | 2026-06-23 | 4,200 | — | $0 | 4,200 | SEC↗ |
| PRAX Praxis Precision Medicines | A Award deriv | 2026-06-10 | 2026-06-12 | 648 | — | $0 | 648 | SEC↗ |
| PRAX Praxis Precision Medicines | A Award | 2026-06-10 | 2026-06-12 | 1,371 | — | $0 | 1,371 | SEC↗ |
| PRAX Praxis Precision Medicines | A Award deriv | 2025-06-26 | 2025-06-27 | 10,520 | — | $0 | 10,520 | SEC↗ |
| SDGR Schrodinger, Inc. | A Award deriv | 2025-06-18 | 2025-06-20 | 9,341 | — | $0 | 9,341 | SEC↗ |
| SDGR Schrodinger, Inc. | A Award | 2025-06-18 | 2025-06-20 | 5,997 | — | $0 | 17,247 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award deriv | 2025-06-11 | 2025-06-13 | 26,400 | — | $0 | 26,400 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award | 2025-06-11 | 2025-06-13 | 5,900 | — | $0 | 17,700 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award deriv | 2024-08-21 | 2024-08-23 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ACET Adicet Bio, Inc. | D To issuer deriv | 2024-08-21 | 2024-08-23 | 18,500 | — | $0 | 0 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award deriv | 2024-08-21 | 2024-08-23 | 18,500 | — | $0 | 18,500 | SEC↗ |
| ACET Adicet Bio, Inc. | D To issuer deriv | 2024-08-21 | 2024-08-23 | 18,500 | — | $0 | 0 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award deriv | 2024-08-21 | 2024-08-23 | 18,500 | — | $0 | 18,500 | SEC↗ |
| ACET Adicet Bio, Inc. | D To issuer deriv | 2024-08-21 | 2024-08-23 | 26,400 | — | $0 | 0 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award deriv | 2024-08-21 | 2024-08-23 | 26,400 | — | $0 | 26,400 | SEC↗ |
| ACET Adicet Bio, Inc. | D To issuer deriv | 2024-08-21 | 2024-08-23 | 30,000 | — | $0 | 0 | SEC↗ |
| SDGR Schrodinger, Inc. | A Award deriv | 2024-06-18 | 2024-06-20 | 8,550 | — | $0 | 8,550 | SEC↗ |
| SDGR Schrodinger, Inc. | A Award | 2024-06-18 | 2024-06-20 | 5,000 | — | $0 | 11,250 | SEC↗ |
| PRAX Praxis Precision Medicines | A Award deriv | 2024-06-05 | 2024-06-06 | 8,566 | — | $0 | 8,566 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award deriv | 2024-06-05 | 2024-06-07 | 26,400 | — | $0 | 26,400 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award | 2024-06-05 | 2024-06-07 | 5,900 | — | $0 | 11,800 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award deriv | 2023-08-14 | 2023-08-16 | 18,500 | — | $0 | 18,500 | SEC↗ |
| ACET Adicet Bio, Inc. | D To issuer deriv | 2023-08-14 | 2023-08-16 | 26,400 | — | $0 | 0 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award deriv | 2023-08-14 | 2023-08-16 | 18,500 | — | $0 | 18,500 | SEC↗ |
| ACET Adicet Bio, Inc. | D To issuer deriv | 2023-08-14 | 2023-08-16 | 18,500 | — | $0 | 0 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award deriv | 2023-08-14 | 2023-08-16 | 26,400 | — | $0 | 26,400 | SEC↗ |
| ACET Adicet Bio, Inc. | D To issuer deriv | 2023-08-14 | 2023-08-16 | 18,500 | — | $0 | 0 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award deriv | 2023-08-14 | 2023-08-16 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ACET Adicet Bio, Inc. | D To issuer deriv | 2023-08-14 | 2023-08-16 | 30,000 | — | $0 | 0 | SEC↗ |
| SDGR Schrodinger, Inc. | A Award deriv | 2023-06-15 | 2023-06-16 | 12,500 | — | $0 | 12,500 | SEC↗ |
| SDGR Schrodinger, Inc. | A Award | 2023-06-15 | 2023-06-16 | 6,250 | — | $0 | 6,250 | SEC↗ |
| PRAX Praxis Precision Medicines | A Award deriv | 2023-06-12 | 2023-06-14 | 28,981 | — | $0 | 28,981 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award deriv | 2023-06-01 | 2023-06-02 | 26,400 | — | $0 | 26,400 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award | 2023-06-01 | 2023-06-02 | 5,900 | — | $0 | 5,900 | SEC↗ |
| SDGR Schrodinger, Inc. | A Award deriv | 2022-06-15 | 2022-06-16 | 14,907 | — | $0 | 14,907 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award deriv | 2022-06-02 | 2022-06-03 | 18,500 | — | $0 | 18,500 | SEC↗ |
| PRAX Praxis Precision Medicines | A Award deriv | 2022-05-26 | 2022-05-27 | 22,753 | — | $0 | 22,753 | SEC↗ |
| SDGR Schrodinger, Inc. | A Award deriv | 2021-06-17 | 2021-06-21 | 8,736 | — | $0 | 8,736 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award deriv | 2021-04-30 | 2021-05-04 | 18,500 | — | $0 | 18,500 | SEC↗ |
| PRAX Praxis Precision Medicines | A Award deriv | 2021-04-13 | 2021-04-15 | 38,579 | — | $0 | 38,579 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award deriv | 2020-09-17 | 2020-09-17 | 30,000 | — | $0 | 30,000 | SEC↗ |
| TORC resTORbio, Inc. | A Award deriv | 2020-06-03 | 2020-06-05 | 14,414 | — | $0 | 14,414 | SEC↗ |
| SDGR Schrodinger, Inc. | A Award deriv | 2020-04-30 | 2020-05-04 | 25,216 | — | $0 | 25,216 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | A Award deriv | 2019-06-10 | 2019-06-11 | 16,500 | — | $0 | 16,500 | SEC↗ |
| TORC resTORbio, Inc. | A Award deriv | 2019-05-08 | 2019-05-09 | 14,414 | — | $0 | 14,414 | SEC↗ |
| TORC resTORbio, Inc. | A Award deriv | 2018-08-14 | 2018-08-15 | 28,828 | — | $0 | 28,828 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | A Award deriv | 2018-05-30 | 2018-06-01 | 12,500 | — | $0 | 12,500 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2018-02-12 | 2018-02-14 | 1,100 | $150.47 | $165.5K | 72,385 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2018-02-12 | 2018-02-14 | 2,022 | $151.26 | $305.8K | 70,363 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2018-02-12 | 2018-02-14 | 400 | $152.62 | $61.0K | 69,963 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2018-02-12 | 2018-02-14 | 300 | $153.69 | $46.1K | 69,663 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2018-02-12 | 2018-02-14 | 1,300 | $149.21 | $194.0K | 73,485 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award deriv | 2018-02-06 | 2018-02-08 | 23,479 | — | $0 | 23,479 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2018-02-06 | 2018-02-08 | 10,125 | — | $0 | 74,785 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2018-02-06 | 2018-02-08 | 12,136 | — | $0 | 64,660 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2018-02-05 | 2018-02-07 | 3,594 | — | $0 | 14,375 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2018-02-05 | 2018-02-07 | 500 | $161.51 | $80.8K | 53,924 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2018-02-05 | 2018-02-07 | 500 | $160.50 | $80.3K | 54,424 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2018-02-05 | 2018-02-07 | 700 | $159.62 | $111.7K | 54,924 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2018-02-05 | 2018-02-07 | 494 | $158.32 | $78.2K | 55,624 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2018-02-05 | 2018-02-07 | 100 | $164.71 | $16.5K | 52,524 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2018-02-05 | 2018-02-07 | 400 | $162.94 | $65.2K | 53,524 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2018-02-05 | 2018-02-07 | 900 | $164.12 | $147.7K | 52,624 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2018-02-05 | 2018-02-07 | 3,594 | $109.14 | $392.2K | 56,118 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2018-02-02 | 2018-02-05 | 1,796 | — | $0 | 14,368 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2018-02-02 | 2018-02-05 | 100 | $169.49 | $16.9K | 52,524 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2018-02-02 | 2018-02-05 | 100 | $168.06 | $16.8K | 52,624 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2018-02-02 | 2018-02-05 | 996 | $166.10 | $165.4K | 52,724 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2018-02-02 | 2018-02-05 | 600 | $165.23 | $99.1K | 53,720 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2018-02-02 | 2018-02-05 | 1,796 | $91.05 | $163.5K | 54,320 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2018-02-01 | 2018-02-05 | 1,900 | $167.44 | $318.1K | 52,524 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2018-01-16 | 2018-01-17 | 1,719 | — | $0 | 3,438 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2018-01-16 | 2018-01-17 | 900 | $157.54 | $141.8K | 54,724 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2018-01-16 | 2018-01-17 | 300 | $159.04 | $47.7K | 54,424 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2018-01-16 | 2018-01-17 | 1,719 | $96.87 | $166.5K | 56,143 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2018-01-16 | 2018-01-17 | 519 | $155.80 | $80.9K | 55,624 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2018-01-02 | 2018-01-03 | 3,438 | — | $0 | 0 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2018-01-02 | 2018-01-03 | 300 | $149.65 | $44.9K | 57,562 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2018-01-02 | 2018-01-03 | 1,600 | $152.06 | $243.3K | 55,287 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2018-01-02 | 2018-01-03 | 675 | $150.87 | $101.8K | 56,887 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2018-01-02 | 2018-01-03 | 3,438 | $73.51 | $252.7K | 57,862 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2018-01-02 | 2018-01-03 | 863 | $152.80 | $131.9K | 54,424 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2017-11-03 | 2017-11-06 | 3,594 | — | $0 | 17,969 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-11-03 | 2017-11-06 | 3,594 | $144.69 | $520.0K | 54,424 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2017-11-03 | 2017-11-06 | 3,594 | $109.14 | $392.2K | 58,018 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2017-11-02 | 2017-11-06 | 1,796 | — | $0 | 16,164 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2017-11-02 | 2017-11-06 | 1,796 | $91.05 | $163.5K | 56,220 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-11-02 | 2017-11-06 | 300 | $145.89 | $43.8K | 54,424 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-11-02 | 2017-11-06 | 1,096 | $144.89 | $158.8K | 54,724 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-11-02 | 2017-11-06 | 400 | $143.54 | $57.4K | 55,820 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-10-31 | 2017-10-31 | 19,016 | $145.26 | $2.76M | 64,124 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-10-31 | 2017-10-31 | 1,400 | $148.40 | $207.8K | 54,624 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-10-31 | 2017-10-31 | 3,400 | $147.75 | $502.4K | 56,024 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-10-31 | 2017-10-31 | 4,700 | $146.52 | $688.6K | 59,424 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-10-31 | 2017-10-31 | 200 | $149.34 | $29.9K | 54,424 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-10-31 | 2017-10-31 | 25,784 | $144.46 | $3.72M | 83,140 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-10-31 | 2017-10-31 | 4,100 | $143.46 | $588.2K | 108,924 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-10-31 | 2017-10-31 | 1,400 | $142.38 | $199.3K | 113,024 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2017-10-16 | 2017-10-18 | 1,718 | — | $0 | 5,157 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2017-10-16 | 2017-10-18 | 1,718 | $96.87 | $166.4K | 116,142 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-10-16 | 2017-10-18 | 300 | $153.42 | $46.0K | 115,842 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-10-16 | 2017-10-18 | 818 | $154.76 | $126.6K | 115,024 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-10-16 | 2017-10-18 | 300 | $155.92 | $46.8K | 114,724 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-10-16 | 2017-10-18 | 300 | $157.38 | $47.2K | 114,424 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2017-10-02 | 2017-10-04 | 3,437 | — | $0 | 3,438 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-10-02 | 2017-10-04 | 1,394 | $151.04 | $210.5K | 116,467 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2017-10-02 | 2017-10-04 | 3,437 | $73.51 | $252.7K | 117,861 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-10-02 | 2017-10-04 | 1,443 | $151.82 | $219.1K | 115,024 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-10-02 | 2017-10-04 | 600 | $152.62 | $91.6K | 114,424 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2017-08-03 | 2017-08-04 | 3,594 | — | $0 | 21,563 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-08-03 | 2017-08-04 | 600 | $153.29 | $92.0K | 117,418 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2017-08-03 | 2017-08-04 | 3,594 | $109.14 | $392.2K | 118,018 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-08-03 | 2017-08-04 | 500 | $155.15 | $77.6K | 114,424 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-08-03 | 2017-08-04 | 2,494 | $154.21 | $384.6K | 114,924 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2017-08-02 | 2017-08-04 | 1,796 | — | $0 | 17,960 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-08-02 | 2017-08-04 | 296 | $156.24 | $46.2K | 114,424 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-08-02 | 2017-08-04 | 600 | $153.93 | $92.4K | 115,120 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-08-02 | 2017-08-04 | 500 | $152.50 | $76.3K | 115,720 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2017-08-02 | 2017-08-04 | 1,796 | $91.05 | $163.5K | 116,220 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-08-02 | 2017-08-04 | 400 | $154.89 | $62.0K | 114,720 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-07-21 | 2017-07-21 | 700 | $158.08 | $110.7K | 120,624 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-07-21 | 2017-07-21 | 1,000 | $158.92 | $158.9K | 119,624 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-07-21 | 2017-07-21 | 400 | $159.85 | $63.9K | 119,224 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-07-21 | 2017-07-21 | 3,464 | $161.38 | $559.0K | 115,760 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-07-21 | 2017-07-21 | 1,336 | $162.04 | $216.5K | 114,424 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2017-07-19 | 2017-07-21 | 6,303 | — | $0 | 6,875 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2017-07-19 | 2017-07-21 | 32,343 | — | $0 | 25,157 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-07-19 | 2017-07-21 | 39,833 | $161.00 | $6.41M | 121,324 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2017-07-19 | 2017-07-21 | 32,343 | $109.14 | $3.53M | 161,157 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2017-07-19 | 2017-07-21 | 6,303 | $96.87 | $610.6K | 128,814 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2017-07-17 | 2017-07-19 | 573 | — | $0 | 13,178 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-07-17 | 2017-07-19 | 473 | $129.61 | $61.3K | 122,611 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-07-17 | 2017-07-19 | 100 | $130.96 | $13.1K | 122,511 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2017-07-17 | 2017-07-19 | 573 | $96.87 | $55.5K | 123,084 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2017-07-03 | 2017-07-06 | 3,438 | — | $0 | 6,875 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-07-03 | 2017-07-06 | 2,222 | $127.38 | $283.0K | 123,727 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-07-03 | 2017-07-06 | 1,216 | $128.57 | $156.3K | 122,511 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2017-07-03 | 2017-07-06 | 3,438 | $73.51 | $252.7K | 125,949 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2017-06-21 | 2017-06-23 | 5,157 | — | $0 | 8,594 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2017-06-21 | 2017-06-23 | 5,157 | $96.87 | $499.6K | 127,668 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-06-21 | 2017-06-23 | 5,157 | $132.87 | $685.2K | 122,511 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2017-06-01 | 2017-06-05 | 5,155 | — | $0 | 18,908 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-06-01 | 2017-06-05 | 5,155 | $126.87 | $654.0K | 122,511 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2017-06-01 | 2017-06-05 | 5,155 | $96.87 | $499.4K | 127,666 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | A Award deriv | 2017-05-31 | 2017-06-01 | 12,500 | — | $0 | 12,500 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2017-05-02 | 2017-05-04 | 8,979 | — | $0 | 19,756 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-05-02 | 2017-05-04 | 8,979 | $121.05 | $1.09M | 122,511 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2017-05-02 | 2017-05-04 | 8,979 | $91.05 | $817.5K | 131,490 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2017-04-05 | 2017-04-07 | 8,021 | — | $0 | 10,313 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2017-04-05 | 2017-04-07 | 8,021 | $73.51 | $589.6K | 130,532 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-04-05 | 2017-04-07 | 8,021 | $114.00 | $914.4K | 122,511 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2017-04-03 | 2017-04-05 | 2,291 | — | $0 | 18,334 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-04-03 | 2017-04-05 | 1,491 | $108.50 | $161.8K | 123,311 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2017-04-03 | 2017-04-05 | 2,291 | $73.51 | $168.4K | 124,802 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-04-03 | 2017-04-05 | 600 | $109.32 | $65.6K | 122,711 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-04-03 | 2017-04-05 | 200 | $110.09 | $22.0K | 122,511 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2017-03-29 | 2017-03-31 | 13,750 | — | $0 | 20,625 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2017-03-29 | 2017-03-31 | 13,750 | $73.51 | $1.01M | 136,261 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-03-29 | 2017-03-31 | 13,750 | $106.65 | $1.47M | 122,511 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-02-13 | 2017-02-15 | 5,122 | $87.67 | $449.0K | 122,511 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award deriv | 2017-02-03 | 2017-02-07 | 24,852 | — | $0 | 24,852 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2017-02-03 | 2017-02-07 | 12,136 | — | $0 | 127,633 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2017-02-03 | 2017-02-07 | 4,794 | $0.01 | $48 | 115,497 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-02-01 | 2017-02-03 | 400 | $85.08 | $34.0K | 112,203 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-02-01 | 2017-02-03 | 1,500 | $85.91 | $128.9K | 110,703 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | A Award deriv | 2016-06-08 | 2016-06-10 | 10,000 | — | $0 | 10,000 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award deriv | 2016-02-02 | 2016-02-04 | 28,735 | — | $0 | 28,735 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-02-02 | 2016-02-04 | 1,100 | $90.89 | $100.0K | 113,878 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-02-02 | 2016-02-04 | 1,275 | $91.80 | $117.0K | 112,603 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2016-02-02 | 2016-02-04 | 14,416 | $0.01 | $144 | 114,978 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2015-11-18 | 2015-11-20 | 10,315 | — | $0 | 30,938 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2015-11-18 | 2015-11-20 | 10,315 | $130.00 | $1.34M | 100,562 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2015-11-18 | 2015-11-20 | 10,315 | $73.51 | $758.3K | 110,877 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award deriv | 2015-07-21 | 2015-07-23 | 34,000 | — | $0 | 34,000 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2015-07-02 | 2015-07-07 | 2,291 | — | $0 | 41,253 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2015-07-02 | 2015-07-07 | 1,297 | $130.63 | $169.4K | 100,562 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2015-07-02 | 2015-07-07 | 100 | $129.54 | $13.0K | 101,859 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2015-07-02 | 2015-07-07 | 500 | $128.12 | $64.1K | 101,959 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2015-07-02 | 2015-07-07 | 394 | $126.69 | $49.9K | 102,459 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2015-07-02 | 2015-07-07 | 2,291 | $73.51 | $168.4K | 102,853 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | A Award deriv | 2015-06-10 | 2015-06-11 | 10,000 | — | $0 | 10,000 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2015-04-02 | 2015-04-06 | 2,291 | — | $0 | 43,544 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2015-04-02 | 2015-04-06 | 2,291 | $73.51 | $168.4K | 102,853 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2015-04-02 | 2015-04-06 | 1,746 | $115.12 | $201.0K | 101,107 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2015-04-02 | 2015-04-06 | 545 | $116.70 | $63.6K | 100,562 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award deriv | 2015-02-03 | 2015-02-05 | 57,500 | — | $0 | 57,500 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2015-02-03 | 2015-02-05 | 17,250 | $0.01 | $173 | 100,562 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2015-02-02 | 2015-02-04 | 788 | $109.80 | $86.5K | 83,412 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2015-02-02 | 2015-02-04 | 300 | $108.64 | $32.6K | 84,200 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2015-02-02 | 2015-02-04 | 100 | $110.85 | $11.1K | 83,312 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2015-01-02 | 2015-01-06 | 2,291 | — | $0 | 45,835 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2015-01-02 | 2015-01-06 | 2,291 | $73.51 | $168.4K | 86,791 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2015-01-02 | 2015-01-06 | 100 | $119.03 | $11.9K | 86,691 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2015-01-02 | 2015-01-06 | 1,200 | $122.35 | $146.8K | 85,491 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2015-01-02 | 2015-01-06 | 991 | $123.12 | $122.0K | 84,500 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2014-10-30 | 2014-11-03 | 75,000 | $0.01 | $750 | 84,500 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2014-10-28 | 2014-10-30 | 3,438 | — | $0 | 48,126 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2014-10-28 | 2014-10-30 | 3,438 | $73.51 | $252.7K | 12,938 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2014-10-28 | 2014-10-30 | 3,438 | $115.00 | $395.4K | 9,500 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2014-10-07 | 2014-10-09 | 3,436 | — | $0 | 51,564 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2014-10-07 | 2014-10-09 | 902 | $103.64 | $93.5K | 12,034 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2014-10-07 | 2014-10-09 | 400 | $105.36 | $42.1K | 9,500 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2014-10-07 | 2014-10-09 | 3,436 | $73.51 | $252.6K | 12,936 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2014-10-07 | 2014-10-09 | 2,134 | $104.31 | $222.6K | 9,900 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award deriv | 2014-07-15 | 2014-07-17 | 27,500 | — | $0 | 27,500 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | A Award deriv | 2014-06-13 | 2014-06-17 | 20,000 | — | $0 | 20,000 | SEC↗ |